The Australasian Professional Society on Alcohol and other Drugs

News & Media

New e-Learning module on hepatitis C available

The Australasian Society for HIV Medicine (ASHM) has launched an eLearning resource titled Diagnosing and Managing HCV in Drug and Alcohol practice”.

The resource comprises a series of 3 smaller modules each built around a case scenario typically found in the drug and alcohol setting. The first case introduces testing and diagnosis, the second case involves assessing the need for treatment whilst managing comorbidities and the third case focuses on identifying advanced liver disease, treatment pathways, monitoring and treatment outcomes. A number of Fellows of the Australasian Chapter of Addiction Medicine have contributed to the development of these modules.

The eLearning can be accessed in the link: http://lms.ashm.org.au and is also accessible through the RACP’s MyResources gateway.

Please click on “access as a guest” to launch the 3 modules

 

Webinar

APSAD Webinar  - 8th December 2014

Naloxone - why YOU should be prescribing before Christmas

Date: Monday, 8th December 2014
Time: 4:30 - 5:30pm AEDT
Presenter: Associate Professor Nicholas Lintzeris
Location: Your Computer


What will be covered in this session
This webinar will give you the information, the confidence and the tools to start prescribing now.
Background to extended distribution of naloxone including historical, international and national context, as well as legal/prescribing issues. 
Naloxone is a well-known and long used medication to reverse effects of opiates in the event of overdose. Yet Australia lags in making this life saving drug more widely available. While scheduling change may be one longer term option, we must not let this further delay extended availability.

About our presenter
Nicholas LINTZERIS; MBBS, FAChAM, PhD
A/Prof Nicholas Lintzeris is the Director Drug & Alcohol Services, SESLHD (Sydney, Australia) and Chief Addiction Medicine Specialist for NSW Health. He is a Foundation Fellow of the Chapter of Addiction Medicine, was awarded his PhD in 2002 from the Australian National University, and completed a NHMRC Post-doctoral Fellowship at the Institute of Psychiatry and South London Maudsley NHS Trust (2002-6).
Nicholas Lintzeris has worked in the field of Addiction Medicine for over 20 years in Melbourne, Sydney and London in clinical, research and policy roles. A key focus has been the treatment of opioid dependence, contributing to National Clinical Guidelines, systematic reviews and leading several randomised controlled trials of opioid pharmacotherapies, including methadone, buprenorphine, diamorphine and LAAM.
Since returning to Australia in 2006, a particular focus of his work has been the development of treatment and policy responses to the misuse of pharmaceutical opioids, an increasing problem in Australia over this time.
He has published over 80 peer review journal papers and book chapters, and is a chief investigator in several longitudinal cohort studies of pharmaceutical opioid users.

To register for this webinar please go to the Webinar page and follow the instructions
APSAD Webinar not to be missed.
Places are limited and will be allocated in order of requests. You will receive acknowledgement that you have been registered to participate and an overview on how to join the webinar (you only need to register once).


We look forward to your participation



 

Did you know that methadone take away doses are currently being reviewed in Victoria

The Victorian Coroners are suggesting that Victoria adopt the Tasmanian methadone take away dose policy which is a maximum of two, non consecutive take away doses per week.  This will have a significant impact upon people's quality of life.  It will also impact upon employers, the families and partners of people who rely upon a methadone treatment program.

Methadone is one of the best evidenced tools for reducing opioid related deaths and it's continued accessibility is vital to ensuring the health and safety of opioid dependent people and the general community.

Please join this campaign: https://www.change.org/p/dr-denis-napthine-and-hon-mary-wooldridge-mp-i-ask-that-you-continue-the-current-victorian-pharmacotherapy-policy-allowing-up-to-5-methadone-take-away-doses-per-week?recruiter=162572074&utm_campaign=mailto_link&utm_medium=email&utm_source=share_petition

 

Clinician Corner - Drug and Alcohol Review Update

Text message reminders improve patient attendance according to a review of the evidence conducted by Joanna Milward and colleagues, now available on Drug and Alcohol Review’s Early View.

Patients who miss their appointments are at risk of poorer outcomes. Missed appointments are costly for services and can result in valuable resources being wasted.

Forgetfulness is one of the most common explanations for missed appointments. Text message appointment reminders are a cost-effective intervention that has been shown to dramatically improve attendance in health-care settings. Text message reminders are often generic but they can be personalised, for example, by including the person’s name. Reminders need to be sent within a week prior to the appointment, with most reminders being sent 1, 2 or 3 days in advance.

The effectiveness of using text message reminders has not been explored in substance use services. However, surveys suggest that the majority of clients have mobile phones and are receptive to communicating via text messages. One potential barrier to communicating via text is the frequency with which some clients change their mobile phone number.

To read more visit the full paper on Early View.
A complimentary PDF of the article is available to APSAD members by emailing This email address is being protected from spambots. You need JavaScript enabled to view it.

A reminder that APSAD members can view the Drug and Alcohol Review online, dating back to the very first issue, simply by logging into the Member's area on the APSAD Website.

Milward J, Lynskey M, Strang J. Solving the problem of non-attendance in substance abuse services. Drug Alcohol Rev 2014 [Epub ahead of print].

 

dar_banner

 

Call for Mentors

APSAD has recently formed an Early Career Researchers (ECR) Committee, which is focused on linking ECRs with senior researchers, and providing networking opportunities. The ECR group is open to APSAD members and currently to non-members.

APSAD is looking for mid or senior-career researchers to join our informal network, and share their experiences and insights with ECRs. Mentoring can be as formal or informal as the mentor and mentee desire. Just by having a sounding board when questions arise; a friendly ear to talk about career options can be invaluable to ECRs starting out in their careers.
To find out more about APSAD and the ECR network, please visit the APSAD website and view our LinkedIn group and join the discussion
Download the form to register your interest in mentoring. Mentors will be listed on the APSAD Website with a link to their biography.

APSAD Conference inaugural ECR Breakfast
We are excited to announce that our first ECR networking event will take place this year at the APSAD Conference. To view the details for this please visit the Conference Website or Click here to register
For further information please contact the APSAD Office Ph: (02) 9252 2281 E: This email address is being protected from spambots. You need JavaScript enabled to view it. or contact our ECR committee representatives via email Suzanne Nielsen This email address is being protected from spambots. You need JavaScript enabled to view it. or Christina Marel This email address is being protected from spambots. You need JavaScript enabled to view it.

APSAD_early_career_researcher

 

Drug and Alcohol Review Update

Drug and Alcohol Review a new virtual issue is available on ‘Managing methamphetamine dependence: interventions and beyond’. This virtual issue brings together papers on pharmacotherapy, psychotherapy and community-based interventions for methamphetamine use.

Click here to view on the Wiley Online Library 

 

 

Registration NOW open for the APSAD Early Career Researchers Breakfast

APSAD is delighted to announce a new event to this year’s conference program for Early Career Researchers (ECR)!
Call-out to Early Career Researchers to join us at the APSAD Conference for an ECR breakfast event. This is a great opportunity to mingle with seniors in the field as well as your own peers at the '2014 APSAD ECR Breakfast'.
 

The National Drug and Alcohol Services Directory (NDASD)

New Website Directory 

Allows users to run easy and comprehensive searches for Alcohol and Other Drug services anywhere across Australia. The project is a collaboration between the Commonwealth Department of Health, Turning Point and Monash University, and is a really useful resource for anyone looking to link in with an Alcohol or Other Drug treatment service in Australia. This includes individual service users, primary health providers, community and public service providers, GPs and other health professionals.

Visit the NDASD directory 

 

 

APSAD Conference Early Bird Registration is Now OPEN

For further details or to register for the conference please visit our conference website: www.apsadconference.com.au 

APSAD_2014_Conference_Postcard_Page_1

 

The Australian National Preventive Health Agency (ANPHA)

The Australian National Preventive Health Agency (ANPHA) has released their final report today on the case for minimum price for alcohol.

You can download the PDF from their website

 

Subcategories